Five-month observation of persistent diabetic macular edema after intravitreal injection of ozurdex implant

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Zalewski, Dominik ^a   Raczyńska, Dorota ^b   Raczyńska, Krystyna ^b  

^a Diagnostic and Microsurgery Center of the Eye Lens   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; RANIBIZUMAB; BEVACIZUMAB; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CATARACT; DIABETIC MACULAR EDEMA; DRUG EFFICACY; DRUG IMPLANT; HUMAN; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PRIORITY JOURNAL; RETINAL THICKNESS; RETROSPECTIVE STUDY; VISUAL ACUITY; AGED; CHEMICALLY INDUCED; DIABETIC RETINOPATHY; DRUG EFFECTS; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; RETINA; TIME;

AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; CATARACT; DEXAMETHASONE; DIABETIC RETINOPATHY; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINA; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84896293310     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/364143     Document Type: Article

References (17)

1. Owen L. A., Hartnett M. E., Soluble mediators of diabetic macular edema: the diagnostic role of aqueous VEGF and cytokine levels in diabetic macular edema. Current Diabetes Reports 2013 13 4 476 480
2. Bhagat N., Grigorian R. A., Tutela A., Zarbin M. A., Diabetic macular edema: pathogenesis and treatment. Survey of Ophthalmology 2009 54 1 1 32 2-s2.0-58449114090 10.1016/j.survophthal.2008.10.001
3. Cho H. Y., Kang S. W., Kim Y. T., Chung S. E., Lee S. W., A three-year follow-up of intravitreal triamcinolone acetonie injection and macular laser photocoagulation for diffuse diabetic macular edema. Korean Journal of Ophthalmology 2012 26 5 362 368
4. Schatz H., Madeira D., McDonald H. R., Johnson R. N., Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Archives of Ophthalmology 1991 109 11 1549 1551 2-s2.0-0026075103
5. Lee H. Y., Lee S. Y., Park J. S., Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema. Korean Journal of Ophthalmology 2009 23 3 153 158 2-s2.0-73349086556
6. Beck R. W., Edwards A. R., Aiello L. P., Bressler N. M., Ferris F., Glassman A. R., Hartnett M. E., Ip M. S., Kim J. E., Kollman C., Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Archives of Ophthalmology 2009 127 3 245 251 2-s2.0-62449171859 10.1001/archophthalmol.2008.610
7. Leopold I. H., Sears M. L., Tarkkanen A., Nonsteroidal and steroidal anti-inflammatory agents. Surgical Pharmacology of the Eye 1985 New York, NY, USA Raven Press
8. Liu D., Ahmet A., Ward L., A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy, Asthma & Clinical Immunology 2013 9, article 30
9. Weijtens O., van der Sluijs F. A., Schoemaker R. C., Lentjes E. G. W. M., Cohen A. F., Romijn F. P. H. T. M., Van Meurs J. C., Peribulbar corticosteroid injection: vitreal and serum concentrations after dexamethasone disodium phosphate injection. American Journal of Ophthalmology 1997 123 3 358 363 2-s2.0-0030972026 (Pubitemid 27123042)
10. Goldfien A., Katzung B. G., Adrenocorticosteroids and adrenocortical antagonists. Basic and Clinical Pharmacology 1995 6th London, UK Prentice Hall International 592 607
11. Beer P. M., Bakri S. J., Singh R. J., Liu W., Peters G. B. III, Miller M., Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003 110 4 681 686 2-s2.0-0037398304 10.1016/S0161-6420(02)01969-3 (Pubitemid 36520063)
12. Martidis A., Duker J. S., Greenberg P. B., Rogers A. H., Puliafito C. A., Reichel E., Baumal C., Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002 109 5 920 927 2-s2.0-0036240895 10.1016/S0161-6420(02)00975-2 (Pubitemid 34465226)
13. Herrero-Vanrell R., Cardillo J. A., Kuppermann B. D., Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema. Clinical Ophthalmology 2011 5 1 139 146 2-s2.0-79952860365 10.2147/OPTH.S15783
14. Pacella E., Vestri A. R., Muscella R., Carbotti M. R., Castellucci M., Coi L., Turchetti P., Pacella F., Preliminary results of an intravitreal dexamethasone implant (Ozurdex) in patients with persistent diabetic macular edema. Clinical Ophthalmology 2013 2013 7 1423 1428
15. Rishi P., Rishi E., Kuniyal L., Mathur G., Short-term results of intravitreal dexamethasone implant (OZURDEX) in treatment of recalcitrant diabetic macular edema: a case series. Oman Journal of Ophthalmology 2012 5 2 79 82
16. Ferrini W., Ambresin A., Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting. Klinische Monatsblätter für Augenheilkunde 2013 230 4 423 426
17. Mayer W. J., Wolf A., Kernt M., Kook D., Kampik A., Ulbig M., Haritoglou C., Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion. Eye 2013 27 7 816 822